Common Contracts
19 similar Change of Control and Severance Benefits Agreement contracts by Transcept Pharmaceuticals Inc
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • March 14th, 2014 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this eleventh day of November 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Leone Patterson (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of July 15, 2013, as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • March 14th, 2014 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this eleventh day of November 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Glenn A. Oclassen (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of July 15, 2013 as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • November 7th, 2013 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is effective the fifteenth day of July 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Leone Patterson (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of May 22, 2012, as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • November 7th, 2013 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is effective the fifteenth day of July 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Thomas P. Soloway (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of April 30, 2009, as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • November 7th, 2013 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is effective the fifteenth day of July 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Nikhilesh Singh, Ph.D., (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of April 30, 2009, as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • November 7th, 2013 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is effective the fifteenth day of July 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and John A. Kollins (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of May 31, 2012, as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • November 7th, 2013 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is effective the fifteenth day of July 2013 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Glenn A. Oclassen (“Executive”). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of April 30, 2009 as amended (the “Prior Agreement”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • June 26th, 2012 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 22nd day of May, 2012 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Leone Patterson (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • June 4th, 2012 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 31st day of May, 2012 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and John A. Kollins (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and DENNIE DYER (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and MARILYN E. WORTZMAN (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and THOMAS P. SOLOWAY (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and SHARON SAKAI, PH.D. (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and NIKHILESH SINGH, PH.D. (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and NIPUN DAVAR, PH.D. (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and GLENN A. OCLASSEN (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and TERRENCE MOORE (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • August 14th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 30 day of April, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and SUSAN KOPPY (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • March 31st, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 4th day of March, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Joseph T. Kennedy (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
